Key Contract Considerations for Industry-Supported Investigator-Initiated Clinical Trial (IIT) Agreements

About this session

Industry-supported investigator-initiated trials present unique contracting challenges that often differ from traditional sponsor-led studies. This session will examine key IIT agreement provisions, including regulatory responsibility, funding, indemnification, subject injury, intellectual property, publication rights, and data ownership. Speakers will discuss common negotiation challenges and practical approaches for balancing investigator independence with appropriate risk allocation among all parties.

Speakers

• 

  Collin Gruener

  Operations Manager, WCG Site Network · WCG

  Speaker

• AL

  Avril Liu

  Associate Director of Sponsored Programs · University of Illinois Chicago

  Speaker

• KM

  Kate Duffy Mazan

  Member · Clinical Technology Transfer Group

  Speaker

• SH

  S. Asra Husain

  Clinical Trial Team Lead · University of Wisconsin-Madison, Office of Research and Sponsored Programs

  Speaker